Researchers bring prostate cancer to a halt

Posted on 2008-11-27 05:31:24 in Cancer | Genetic Engineering | Men's Health |
Researchers have managed to stop the development of prostate cancer in mice by inactivating a biomarker for aggressive prostate cancer.

The glucose-regulated protein GRP78 is vital in the development of prostate cancer as it promotes cancer cell proliferation, mediates oncogenic signaling, and protects cancer cells from cell death. Professor Amy Lee and colleagues investigated prostate cancer development in mice in which GRP78 had been inactivated. The PTEN tumor suppressor gene had also been inactivated in the mice, as the loss of PTEN is implicated in the development of many human cancers. Results showed that prostate cancer activation and development resulting from the loss of PTEN was prevented by inactivating GRP78.

According to Professor Lee, the findings have “far-reaching implications” for a wide range of human cancers. She is calling for further research to test the role of GRP78 in other cancers and to develop drugs that inhibit GRP78 as she believes that “anti-GRP78 therapy may open up an entirely new approach to stop human cancer.”

Fu Y, Wey S, Wand M, Ye R, Liao CP, Roy-Burman P, Lee AS. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. PNAS Published online before print November 25, 2008. doi:10.1073/pnas.0807691105

News release: Researchers Identify Novel Approach For Suppressing Prostate Cancer Development. University of Southern California Health Sciences. November 23rd 2008.


Health Headlines

In a lab animal model, booming gut flora spawned by the Western diet is linked to obesity.
International study reaffirms importance of resolving the income gap between the richest and poorest people in developed countries.
Switzerland-based research team assesses the metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress hormones.
UCLA researchers find disability rates in Americans entering their 60s are on the rise, potentially fueled by the overweight/obesity epidemic.
Genetic clues to longevity discovered among a homogenous ethnic population.
Rush Alzheimer's Disease Center (USA) researchers find that a loss of muscle strength raises risk of Alzheimer’s Disease and mild cognitive impairment.
Stroke risk may rise in those with common infectious pathogens such as Chlamydia pneumoniae, Helicobacter pylori, and herpes simplex viruses.
First study in humans links bisphenol A (BPA) exposure to male sexual function problems.
Simple steps in the community can promote walking among residents.
Study finds that people who are dissatisfied with their workplace bosses not only take more sick leave, but are at increased risk of suffering a heart attack.
Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Las Vegas
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010

VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health (PATH Medical), Chairs the Brain Age Workshop taking place Dec. 9, 2009. Held in conjunction with the Winter Session of the 17th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies. The Brain Age Workshop features presentations on Brain Mind Assessment via Neuropsychological Analysis, Movement Deficiency Syndrome, Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain Injury. View this video to learn about Dr. Braverman’s brain-based model of aging and age modulation.

International Events
See all events »